BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 18158770)

  • 21. Prolongation of the survival of breast cancer-bearing mice immunized with GM-CSF-secreting syngeneic/allogeneic fibroblasts transfected with a cDNA expression library from breast cancer cells.
    Kim TS; Jung MY; Cho D; Cohen EP
    Vaccine; 2006 Oct; 24(42-43):6564-73. PubMed ID: 16837111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
    Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM
    Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of cytokine gene transfection may differ for autologous and allogeneic tumour cell vaccines.
    Todryk SM; Birchall LJ; Erlich R; Halanek N; Orleans-Lindsay JK; Dalgleish AG
    Immunology; 2001 Feb; 102(2):190-8. PubMed ID: 11260324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
    J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin‑15: a potent adjuvant enhancing the efficacy of an autologous whole‑cell tumor vaccine against Lewis lung carcinoma.
    Chen X; Ni J; Meng H; Li D; Wei Y; Luo Y; Wu Y
    Mol Med Rep; 2014 Oct; 10(4):1828-34. PubMed ID: 25109355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model.
    Lumniczky K; Desaknai S; Mangel L; Szende B; Hamada H; Hidvegi EJ; Safrany G
    Cancer Gene Ther; 2002 Jan; 9(1):44-52. PubMed ID: 11916244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma.
    Chu Y; Wang LX; Yang G; Ross HJ; Urba WJ; Prell R; Jooss K; Xiong S; Hu HM
    J Immunother; 2006; 29(4):367-80. PubMed ID: 16799332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [GM-CSF gene-modified dendritic cell vaccine enhances antitumor immunity in vitro].
    He SB; Sun K; Wang L; Li DC; Zhang YY
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):410-4. PubMed ID: 20819479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro inducing effect of dendritic cells cotransfected with survivin and granulocyte-macrophage colony-stimulating factor on cytotoxic T cell to kill leukemic cells.
    Zhu XP; Chen ZZ; Li CT; Lin X; Zhuang JL; Hu JD; Yang T; Xu ZS
    Chin Med J (Engl); 2008 Nov; 121(21):2180-4. PubMed ID: 19080181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy with GM-CSF, interleukin-4 and herpes simplex virus thymidine kinase shows strong antitumor effect on lung cancer.
    Park KH; Kim G; Jang SH; Kim CH; Kwon SY; Yoo CG; Kim YW; Kwon HC; Kim CM; Han SK; Shim YS; Lee CT
    Anticancer Res; 2003; 23(2B):1559-64. PubMed ID: 12828142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.
    Sampson JH; Archer GE; Ashley DM; Fuchs HE; Hale LP; Dranoff G; Bigner DD
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10399-404. PubMed ID: 8816812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells.
    Guo J; Zhang M; Wang B; Yuan Z; Guo Z; Chen T; Yu Y; Qin Z; Cao X
    Int J Cancer; 2003 Jan; 103(2):212-20. PubMed ID: 12455035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GM-CSF and B7-1 (CD80) co-stimulatory signals co-operate in the induction of effective anti-tumor immunity in syngeneic mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Hamada H; Azuma M; Asano S
    Int J Cancer; 1997 Nov; 73(4):556-61. PubMed ID: 9389572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice.
    Nagai E; Ogawa T; Kielian T; Ikubo A; Suzuki T
    Cancer Immunol Immunother; 1998 Oct; 47(2):72-80. PubMed ID: 9769115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
    Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response and survival of refractory cancer patients who received TGF-β2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine.
    Nemunaitis J; Senzer N; Olivares J; Kumar P; Barve M; Kuhn J; Nemunaitis T; Magee M; Yu Y; Wallraven G; Pappen BO; Maples PB
    Gene Ther; 2013 Sep; 20(9):875-9. PubMed ID: 23466552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Application of fusion gene mGM-CSF/hIL-2 to specific immunotherapy induced by hepatic tumor cell vaccine].
    Yang W; Guo C; Liu QG
    Ai Zheng; 2008 Feb; 27(2):149-54. PubMed ID: 18279611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor effects obtained by autologous Lewis lung cancer cell vaccine engineered to secrete mouse interleukin 27 by means of cationic liposome.
    Zhang J; Tian H; Li C; Cheng L; Zhang S; Zhang X; Wang R; Xu F; Dai L; Shi G; Chen X; Li Y; Du T; Deng J; Liu Y; Yang Y; Wei Y; Deng H
    Mol Immunol; 2013 Oct; 55(3-4):264-74. PubMed ID: 23522926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.